Trial NCT02750514

View at ClinicalTrials.gov 
Org. Study IDs: CA018-001

Last trial update was posted on 2021-03-22

MeSH Interventions

Dasatinib Ipilimumab Linrodostat Nivolumab Relatlimab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Advanced Cancer

Stopping Reasons

The standard of care for the patient population changed and we were unable to accrue any longer.

Limitations And Caveats

This study was terminated early by sponsor for reasons unrelated to safety.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID